Sep 13, 2018 Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease Enzyme replacement therapy and white matter hyperintensity progression in Fabry diseaseMethods Patients with a confirmed diagnosis of FD, aged 18 years or older, participating in an existing FD observational study (NCT00196742), with at ... read morePublished on 2018-09-13